Memorias do Instituto Oswaldo Cruz

(The TQCC of Memorias do Instituto Oswaldo Cruz is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease25
The translational challenge in Chagas disease drug development24
Do the new triatomine species pose new challenges or strategies for monitoring Chagas disease? An overview from 1979-202123
Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy21
Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells19
Chagas disease control-surveillance in the Americas: the multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission18
Parasitological, serological and molecular diagnosis of acute and chronic Chagas disease: from field to laboratory13
Family Herpesviridae and neuroinfections: current status and research in progress11
Emerging and reemerging forms of Trypanosoma cruzi transmission11
The multidimensional comprehension of Chagas disease. Contributions, approaches, challenges and opportunities from and beyond the Information, Education and Communication field11
Perspectives for a new drug candidate for Chagas disease therapy11
Systematic review on the biology, ecology, genetic diversity and parasite transmission potential of Panstrongylus geniculatus (Latreille 1811) in Latin America11
Fast surveillance response reveals the introduction of a new yellow fever virus sub-lineage in 2021, in Minas Gerais, Brazil10
Medicines for Malaria Venture COVID Box: a source for repurposing drugs with antifungal activity against human pathogenic fungi10
Prognosis of chronic Chagas heart disease and other pending clinical challenges10
Genomics and functional genomics in Leishmania and Trypanosoma cruzi: statuses, challenges and perspectives10
Why do we still have not a vaccine against Chagas disease?9
Chagas disease in the context of the 2030 agenda: global warming and vectors9
Population movements, borders, and Chagas disease9
Comparison of viral load between saliva and nasopharyngeal swabs for SARS-CoV2: the role of days of symptoms onset on diagnosis9
Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target8
Evaluation of LAMP for the diagnosis of Loa loa infection in dried blood spots compared to PCR-based assays and microscopy8
Computational approaches towards the discovery and optimisation of cruzain inhibitors8
Accuracy of rapid point-of-care serological tests for leprosy diagnosis: a systematic review and meta-analysis8
Urban infestation by Triatoma infestans (Hemiptera: Reduviidae), an overlooked phenomena for Chagas disease in Argentina7
Mycolicibacterium fortuitum genomic epidemiology, resistome and virulome7
Mechanism of action of glycyrrhizin against Plasmodium falciparum6
Molecular detection of omicron SARS-CoV-2 variant is achieved by RT-LAMP despite genomic mutations6
Gene expression of Paracoccidioides virulence factors after interaction with macrophages and fibroblasts6
Transmission-blocking compound candidates against Plasmodium vivax using P. berghei as an initial screening6
Flight tone characterisation of the South American malaria vector Anopheles darlingi (Diptera: Culicidae)6
Is the mitochondrion a promising drug target in trypanosomatids?6
A history of over 40 years of potentially pathogenic free-living amoeba studies in Brazil - a systematic review6
Validation of ELISA with recombinant antigens in serological diagnosis of canine Leishmania infantum infection6
Epidemiology of paracoccidioidomycosis in Venezuela: a retrospective study from 1954 to 20195
An emerging paradigm for the origin and evolution of shelled amoebae, integrating advances from molecular phylogenetics, morphology and paleontology5
Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach*5
Transmission cluster of COVID-19 cases from Uruguay: emergence and spreading of a novel SARS-CoV-2 ORF6 deletion5
Critical analysis of Chagas disease treatment in different countries5
How people affected by Chagas disease have struggled with their negligence: history, associative movement and World Chagas Disease Day5
Differential expression profiles of miRNAs and their putative targets in Schistosoma mansoni during its life cycle5
Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease5
Antigenicity and adhesiveness of a Plasmodium vivax VIR-E protein from Brazilian isolates5
Significance of a neglected tropical disease: lessons from a paradigmatic case of ‘success in translation’4
Clinical and epidemiological aspects of Delta and Gamma SARS-CoV-2 variant of concern from the western Brazilian Amazon4
Enterovirus infection and its relationship with neurodegenerative diseases4
Should COVID-19 be branded to viral thrombotic fever?4
Detection of non-tuberculosus mycobacteria (NTMs) in lung samples using 16S rRNA4
Multidisciplinary approach detects speciation within the kissing bug Panstrongylus rufotuberculatus populations (Hemiptera, Heteroptera, Reduviidae)4
Inhibition of nitric oxide production of activated mice peritoneal macrophages is independent of the Toxoplasma gondii strain4
Sand fly behavior: much more than weak-flying4
Toxoplasma gondii in the faeces of wild felids from the Atlantic Forest, Brazil4
Evaluation of cytochrome b sequence to identify Leishmania species and variants: the case of Panama4
The adaptation of SARS-CoV-2 to humans4